G1 Therapeutics, Inc.
Biotechnology ResearchNorth Carolina, United States51-200 Employees
G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos.
G1 Therapeutics, Inc. uses 8 technology products and services including Akamai, Drupal, OneTrust, and more. Explore G1 Therapeutics, Inc.'s tech stack below.
| G1 Therapeutics, Inc. Email Formats | Percentage |
| FLast@g1therapeutics.com | 93% |
| FirstLast@g1therapeutics.com | 5% |
| First.Last@g1therapeutics.com | 1% |
| FirLast@g1therapeutics.com | 1% |
Biotechnology ResearchNorth Carolina, United States51-200 Employees
G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos.
G1 Therapeutics, Inc. has raised a total of $461M of funding over 5 rounds. Their latest funding round was raised on Feb 22, 2019 in the amount of $5M.
G1 Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M
G1 Therapeutics, Inc. has raised a total of $461M of funding over 5 rounds. Their latest funding round was raised on Feb 22, 2019 in the amount of $5M.
G1 Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M